Emily Butler, PhD
Dr. Butler joined ProKidney in April 2021 as Director, Biostatistics. She was promoted to Vice President, Biometrics in 2022 and built the Biostatistics, Data Management, Statistical Programming and Data Science functions. She is responsible for owning, managing, analyzing and reporting data across the portfolio and has served as Senior Vice President, Biometrics since 2023. Prior to ProKidney, Dr. Butler worked at GlaxoSmithKline supporting the oncology therapeutic area. She led the early phase development of the cell therapy asset in both solid tumor and hematological malignancies. Dr. Butler has a PhD in Biostatistics from the University of North Carolina at Chapel Hill and a BS in Statistics from Carnegie Mellon University.